107
Publications
2.2K
Citations
19
H-Index
23
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 5 | 5 | 571 |
2 | Cell Biology | 5 | 5 | 571 |
3 | Engineering | 1 | 1 | 64 |
4 | Biomedical Engineering | 1 | 1 | 64 |
5 | Immunology | 1 | 1 | 19 |
Al Charest
×
15
Publications
1.7K
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
2008 | 281 | |
2022 | 278 | |
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations Helen Y. Zou, Qiuhua Li, Lars D. Engstrom, Proceedings of the National Academy of Sciences Inhibitory ActivityRadiation OncologyFusion KinasesNovel TherapyCrizotinib-resistant Ros1 Mutations | 2015 | 267 |
2009 | 228 | |
2006 | 165 | |
2016 | 91 | |
2009 | 64 | |
2019 | 64 | |
2018 | 42 | |
2014 | 40 |
Page 1
Page 1